Veracity GLP-1 Boosters Deceptive Advertising Claims

Prescription GLP-1 agonists like Ozempic have been clinically shown to contribute to significant weight loss. These prescription medications mimic GLP-1 but last much longer in the body—often for days—keeping GLP-1 receptors activated at a steady, therapeutic level. This sustained activation is what leads to significant appetite reduction, slower digestion, better blood sugar control, and, in many cases, substantial weight loss.

Unlike actual prescription GLP-1 medications, supplements that claim to “boost” GLP-1 usually cause only a tiny, short-lived increase in your body’s natural GLP-1 hormone. This effect is often too small to meaningfully affect appetite, weight, or blood sugar.

We are investigating whether Veracity may have violated consumer protection laws by comparing the effects of their booster supplements to actual GLP-1 agonists like Ozempic and potentially giving consumers the false impression that they can achieve similar results.

By filling out the form, you are expressing your interest to learn more about participating in a class action as one of the class representatives. As a class representative, your job is to look out for the best interests of the class and assist Zimmerman Reed in pursuing the case.

No, there is no cost to you. You will sign an agreement for Zimmerman Reed to represent you in a potential class action, but we only get paid if we obtain a financial recovery. If Zimmerman Reed is not successful in getting financial compensation for you or the class, you will owe us nothing.

After filling out the form, you will be prompted to schedule an initial phone call with a Zimmerman Reed representative who will answer any questions and complete your intake process.